Citigroup’s Upgrade Caps a Run of Bullish Calls on PTC Therapeutics, a Major Armistice Capital Holding

Citigroup’s recent upgrade of PTC Therapeutics spotlights a growing wave of optimism around this major Armistice Capital holding. Though full details lie behind a paywall, the upturn in positive analyst attention remains clear.